Vitrakvi 20 mg (Larotrectinib (Larotrectinib Sulfate) SOLUTION) 20 MG

VITRAKVI 20 MG is an oral solution containing larotrectinib (larotrectinib sulfate), a medication used for targeted therapy. This solution is designed to address specific medical conditions related to genetic mutations.

Strength

20 MG

Manufacturer / TM Owner

BAYER INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VITRAKVI 20 MG is primarily used for the treatment of advanced solid tumors in patients with specific genetic mutations. Larotrectinib, the active ingredient, targets these mutations to help manage the growth of cancer cells. This medication is often considered when other treatments have not been effective.

Side Effects

Common effects of VITRAKVI 20 MG may include fatigue, nausea, and dizziness. Some individuals might experience changes in taste or vision. It is important to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

VITRAKVI 20 MG should be handled with care, especially if you have a history of heart problems or are taking other medications. It is crucial to follow the prescribed dosage and administration instructions provided by your healthcare provider. Always store the solution as directed to maintain its effectiveness.

Avoid Interactions

VITRAKVI 20 MG may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be used with caution.

Frequently Asked Questions

VITRAKVI 20 MG is used to treat advanced solid tumors in patients with specific genetic mutations.

VITRAKVI 20 MG is an oral solution that should be taken as directed by your healthcare provider.

Common side effects may include fatigue, nausea, dizziness, and changes in taste or vision.

Yes, VITRAKVI 20 MG may interact with medications that affect liver enzymes, so it is important to consult your healthcare provider.

VITRAKVI 20 MG should be stored according to the instructions provided to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.